Practice Point® CME Podcasts: Expert Discussions in Rare Diseases™
In these podcasts, we dive deep into the world of rare diseases, where every story is unique and every diagnosis a challenge. The episodes highlight the personal journeys of patients and medical professionals as they navigate the complexities of rare conditions. Each episode features expert insights on cutting-edge research, emerging treatments, and the social and emotional aspects of living with a rare disease. These podcasts are your guide to understanding and advocating for those affected by these often misunderstood conditions.
Episodes
Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk.
Launch Date: August 25, 2025
R...
Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk.
Launch Date: August 25, 2025
R...
Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk.
Launch Date: August 25, 2025
R...
Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk.
Launch Date: August 25, 2025
R...
Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk.
Launch Date: August 25, 2025
R...
Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk.
Launch Date: August 25, 2025
R...
Stay informed on the go with our expert-led podcast series dedicated to stroke prevention. Across seven short episodes, Dr.'s C. Michael Gibson and Manesh Patel explore the shifting landscape of antithrombotic therapy—especially the potential role of Factor XIa inhibitors. From trial data to clinical applications, this series distills what you need to know to enhance patient care and reduce stroke risk.
Launch Date: August 25, 2025
R...
The introduction of kinase inhibitors has significantly impacted the treatment landscape of plexiform neurofibromas (PN) associated with neurofibromatosis type 1 (NF1). In this podcast activity from the 2025 Annual Oncology Meeting, noteworthy data in NF1-PN has been summarized and evaluated by Dr. Amy Armstrong. This activity is AMA/ABS/ANCC/ACPE accredited for one-year.
Launch Date: June 5, 2025
Release Date: June 5, 2025
Expiration...
There continues to be significant progress in the treatment of primary biliary cholangitis (PBC) and these Clinical Clips from EASL 2025 have focused on the most impactful data presented at this conference. Dr. Nancy Reau will summarize key advances from Day 2 of EASL 2025 and describe their implications for clinical practice.
Launch Date: May 13, 2025
Release Date: May 13, 2025
Expiration Date: April 30, 2026
FACULTY
Nancy Reau, MD
Sect...
There continues to be significant progress in the treatment of primary biliary cholangitis (PBC) and these Clinical Clips from EASL 2025 have focused on the most impactful data presented at this conference. Dr. Nancy Reau will summarize key advances from Day 1 of EASL 2025 and describe their implications for clinical practice.
Launch Date: May 13, 2025
Release Date: May 13, 2025
Expiration Date: April 30, 2026
FACULTY
Nancy Reau, MD
Sect...
In this podcast titled "Emerging Evidence in Myasthenia Gravis: Key Updates from AAN 2025," Dr. Nicholas Silvestri provides healthcare professionals with an actionable update on recent advancements in MG; which features insights from groundbreaking research presented at AAN 2025.
Launch Date: April 30, 2025
Release Date: April 30, 2025
Expiration Date: March 31, 2026
FACULTY
Nicholas Silvestri, MD, FAAN
Professor of Neurology, Associate ...
Join Dr. Nicholas Silvestri in this 8-minute, special edition podcast series on myasthenia gravis (MG). Today’s podcast titled, The Future of MG Care: Innovations in Diagnostics and Guidelines, looks ahead at emerging technologies and the need for standardized international guidelines to harmonize MG management.
Launch Date: April 28, 2025
Release Date: April 28, 2025
Expiration Date: March 31, 2026
FACULTY
Nicholas Silvestri, MD, FAAN
P...
Join Dr. Nicholas Silvestri in this 9-minute, special edition podcast series on myasthenia gravis (MG). Today’s podcast titled, Tailoring Treatment: The Role of Serotype Testing, discusses the impact of serotype testing on treatment decisions, including differences in therapeutic approaches for AChR-positive, MuSK-positive, and LRP4-positive patients.
Launch Date: April 24, 2025
Release Date: April 24, 2025
Expiration Date: March 31, ...
Join Dr. Nicholas Silvestri in this 10-minute, special edition podcast series on myasthenia gravis (MG). Today’s podcast titled, Innovations in MG Therapeutics, focuses on the latest therapies, including complement inhibitors and FcRn antagonists, and their application in personalized treatment plans.
Launch Date: April 21, 2025
Release Date: April 21, 2025
Expiration Date: March 31, 2026
FACULTY
Nicholas Silvestri, MD, FAAN
Professor of...
Join Dr. Nicholas Silvestri in this 8-minute, special edition podcast series on myasthenia gravis (MG). Today’s podcast titled, Advancements in Myasthenia Gravis Diagnosis, highlights the limitations of traditional diagnostic methods and introduces emerging technologies such as high-sensitivity serotype testing and advanced neurophysiological techniques.
Launch Date: April 17, 2025
Release Date: April 17, 2025
Expiration Date: March 3...
Please refer to the activity landing page for the downloadable slides.
Primary biliary cholangitis (PBC) is a chronic, cholestatic, autoimmune liver disease that can progress to end-stage liver disease. Recent developments have led to important updates in the diagnosis and use of novel approaches in treatment for patients with PBC. This podcast will utilize case-based discussion to address implications of risk stratification and pra...
Several new developments in primary biliary cholangitis (PBC) on available and emerging therapies were presented at AASLD 2024. In these podcasts, Dr. Ashwani K. Singal will discuss the most important breakthroughs in the understanding and treatment of PBC and will provide guidance on their impact.
Launch Date: November 26, 2024
Release Date: November 26, 2024
Expiration Date: October 31, 2025
FACULTY
Ashwani K. Singal, MD, MS, FACG, FA...
Several new developments in primary biliary cholangitis (PBC) on available and emerging therapies were presented at AASLD 2024. In these podcasts, Dr. Ashwani K. Singal will discuss the most important breakthroughs in the understanding and treatment of PBC and will provide guidance on their impact.
Launch Date: November 26, 2024
Release Date: November 26, 2024
Expiration Date: October 31, 2025
FACULTY
Ashwani K. Singal, MD, MS, FACG, FA...
This podcast features an engaging discussion between Dr. Douglas Dieterich and his patient with long-standing PBC, on the patient’s insights and experiences with her disease and treatment. The activity will enable participants to understand the importance of listening to patient perspectives when designing individualized care pathways to alleviate symptoms and improve quality of life.
Launch Date: November 21, 2024
Release Date: Nove...
This podcast features an engaging discussion between Dr. David Victor and his patient, with long-standing PBC, on the patient’s insights and experiences with her disease and treatment. The activity will enable participants to understand the importance of listening to patient perspectives when designing individualized care pathways to alleviate symptoms and improve quality of life.
Launch Date: October 24, 2024
Release Date: October 2...
Popular Podcasts
The latest news in 4 minutes updated every hour, every day.
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
The Clay Travis and Buck Sexton Show. Clay Travis and Buck Sexton tackle the biggest stories in news, politics and current events with intelligence and humor. From the border crisis, to the madness of cancel culture and far-left missteps, Clay and Buck guide listeners through the latest headlines and hot topics with fun and entertaining conversations and opinions.
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Charlie is America's hardest working grassroots activist who has your inside scoop on the biggest news of the day and what's really going on behind the headlines. The founder of Turning Point USA and one of social media's most engaged personalities, Charlie is on the front lines of America’s culture war, mobilizing hundreds of thousands of students on over 3,500 college and high school campuses across the country, bringing you your daily dose of clarity in a sea of chaos all from his signature no-holds-barred, unapologetically conservative, freedom-loving point of view. You can also watch Charlie Kirk on Salem News Channel